Name: EU regulator backs J&J vaccine, despite risk
Uploaded: 2021-04-20T16:50:15+00:00
Duration: 2 min 5 s
Description: Europe's drug regulator has found a possible link between Johnson & Johnson's COVID-19 vaccine and rare blood clotting issues in adults who received doses in the United States, but backed its overall

4 years ago

13.2K

Europe's drug regulator has found a possible link between Johnson & Johnson's COVID-19 vaccine and rare blood clotting issues in adults who received doses in the United States, but backed its overall benefits against any risks. Olivia Chan reports.

Loading comments...

Premium Only Content

EU regulator backs J&J vaccine, despite risk

Comments

Premium Only Content

EU regulator backs J&J vaccine, despite risk

Reuters

After Brazil’s deadly police raid, a woman fights to clear her husband’s name

Reuters

Biden says vaccine plan on track despite J&J pause

WFTS

CDC delays J&J vaccine recommendations

Reuters

J&J files for U.S. COVID-19 vaccine authorization

Reuters

J&J COVID-19 vaccine 66% effective globally

Reuters

J&J pause shouldn't prompt vaccine hesitancy: Fauci

Reuters

U.S. could roll out J&J vaccine next week

Newsy

Global COVID Cases Grow Despite Vaccine Efforts

KGTV

Downtown Vaccine Super Station remains open despite rain

Reuters

J&J partner disposed of spoilt COVID vaccine batch

Comments